Joint working has become something of the norm in the last decade, but have we taken the time to step back, take stock and see if we are doing it right?
While immunotherapy has transformed the treatment of many cancers, it has failed to make much of an impact in advanced ovarian cancer, and AstraZeneca is hoping to change